Suzuka University of Medical Science · Faculty of Pharmaceutical Sciences / Graduate School of Pharmaceutical Sciences

Research keywordsCu-64/Cu-67を含有する新規悪性腫瘍診断治療薬開発研究、糖尿病治療薬・Morin・DNA・damage・Catalase・医学・歯学・薬学・保健

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Inhibitory Effect of Zinc on Colorectal Cancer by Granzyme B Transcriptional Regulation in Cytotoxic T Cells2023 · International Journal of Molecular Sciences
• Concomitant lansoprazole ameliorates cisplatin-induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats2020 · Biopharm Drug Dispos
• Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: Immediate deamination during catalytic hydrogenation
• Development of the simultaneous LC/MS/MS analysis method for donepezil and memantine in the serum of patients with Alzheimer's disease

• Cu-64/67標識新規アミノ酸を用いたLAT1標的化悪性腫瘍診断／治療薬の開発
• 新規アミノ酸ATSMaaを利用した次世代Cu-64標識NET診断／治療薬の開発
• 新規64Cu標識ソマトスタチン誘導体を基盤とした次世代NET診断／治療薬の開発
• 放射性薬剤の投与設計を最適化すると核医学治療の治療効果が増大する

• Official profile
• ORCID